SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Grace Lai-Hung Wong, Henry Lik-Yuen Chan, Hoi-Yun Chan, Chi-Hang Tse, Angel Mei-Ling Chim, Angeline Oi-Shan Lo, Vincent Wai-Sun Wong, Adverse Effects of Vitamin D Deficiency on Outcomes of Patients With Chronic Hepatitis B, Clinical Gastroenterology and Hepatology, 2015, 13, 4, 783

    CrossRef

  2. 2
    C. C. N. Chong, G. L. H. Wong, V. W. S. Wong, P. C. T. Ip, Y. S. Cheung, J. Wong, K. F. Lee, P. B. S. Lai, H. L. Y. Chan, Antiviral therapy improves post-hepatectomy survival in patients with hepatitis B virus-related hepatocellular carcinoma: a prospective-retrospective study, Alimentary Pharmacology & Therapeutics, 2015, 41, 2
  3. 3
    M. Demir, J. Nigemeier, F. Kütting, A. Bowe, C. Schramm, V. Hoffmann, D. Waldschmidt, T. Goeser, H-M. Steffen, Clinical management of chronic hepatitis B infection: results from a registry at a German tertiary referral center, Infection, 2015,

    CrossRef

  4. 4
    Jean-Claude Trinchet, Valérie Bourcier, Cendrine Chaffaut, Mohand Ait Ahmed, Setty Allam, Patrick Marcellin, Dominique Guyader, Stanislas Pol, Dominique Larrey, Victor De Lédinghen, Denis Ouzan, Fabien Zoulim, Dominique Roulot, Albert Tran, Jean-Pierre Bronowicki, Jean-Pierre Zarski, Odile Goria, Paul Calès, Jean-Marie Péron, Laurent Alric, Marc Bourlière, Philippe Mathurin, Jean-Frédéric Blanc, Armand Abergel, Lawrence Serfaty, Ariane Mallat, Jean-Didier Grangé, Catherine Buffet, Yannick Bacq, Claire Wartelle, Thông Dao, Yves Benhamou, Christophe Pilette, Christine Silvain, Christos Christidis, Dominique Capron, Gérard Thiefin, Sophie Hillaire, Vincent Di Martino, Pierre Nahon, Sylvie Chevret, Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort), Hepatology, 2015, 61, 4
  5. 5
    Ezequiel Ridruejo, Does hepatitis B virus therapy reduce the risk of hepatocellular carcinoma?, Expert Opinion on Drug Safety, 2015, 14, 3, 439

    CrossRef

  6. 6
    G. V. Papatheodoridis, S. Manolakopoulos, G. Touloumi, G. Nikolopoulou, M. Raptopoulou-Gigi, C. Gogos, I. Vafiadis-Zouboulis, D. Karamanolis, A. Chouta, A. Ilias, C. Drakoulis, K. Mimidis, I. Ketikoglou, E. Manesis, M. Mela, G. Hatzis, G. N. Dalekos, Hepatocellular carcinoma risk in HBeAg-negative chronic hepatitis B patients with or without cirrhosis treated with entecavir: HepNet.Greece cohort, Journal of Viral Hepatitis, 2015, 22, 2
  7. 7
    Tung-Hung Su, Jia-Horng Kao, Improving clinical outcomes of chronic hepatitis B virus infection, Expert Review of Gastroenterology & Hepatology, 2015, 9, 2, 141

    CrossRef

  8. 8
    Grace Lai-Hung Wong, Henry Lik-Yuen Chan, Zhuo Yu, Catherine Ka-Yan Wong, Calvin Leung, Patricia Po-Lai Ho, Candace Yim Chan, Vivian Chi-Yee Chung, Zhan Cham-Yan Chan, Yee-Kit Tse, Angel Mei-Ling Chim, Tina Kit-Ting Lau, Hoi-Yun Chan, Chi-Hang Tse, Vincent Wai-Sun Wong, Noninvasive assessments of liver fibrosis with transient elastography and Hui index predict survival in patients with chronic hepatitis B, Journal of Gastroenterology and Hepatology, 2015, 30, 3
  9. 9
    Mauro Viganò, Federica Invernizzi, Pietro Lampertico, Optimal therapy of chronic hepatitis B: how do I treat my HBeAg-negative patients?, Liver International, 2015, 35,
  10. 10
    Vincent Wai-Sun Wong, Pietro Lampertico, Victor de Lédinghen, Pik Eu Chang, Seung Up Kim, Yongpeng Chen, Henry Lik-Yuen Chan, Giampaolo Mangia, Juliette Foucher, Wan Cheng Chow, Sang Hoon Ahn, Jinlin Hou, Probability-Based Interpretation of Liver Stiffness Measurement in Untreated Chronic Hepatitis B Patients, Digestive Diseases and Sciences, 2015,

    CrossRef

  11. 11
    Xieer Liang, Jun Cheng, Yongtao Sun, Xinyue Chen, Tong Li, Hao Wang, Jianning Jiang, Xiaoping Chen, Hui Long, Hong Tang, Yanyan Yu, Jifang Sheng, Shijun Chen, Junqi Niu, Hong Ren, Junping Shi, Xiaoguang Dou, Mobin Wan, Jiaji Jiang, Qing Xie, Guangfeng Shi, Qin Ning, Chengwei Chen, Deming Tan, Hong Ma, Jian Sun, Jidong Jia, Hui Zhuang, Jinlin Hou, Randomized, three-arm study to optimize lamivudine efficacy in hepatitis B e antigen-positive chronic hepatitis B patients, Journal of Gastroenterology and Hepatology, 2015, 30, 4
  12. You have free access to this content12
    H. Chi, B. E. Hansen, C. Yim, P. Arends, M. Abu-Amara, A. A. Eijk, J. J. Feld, R. J. Knegt, D. K. H. Wong, H. L. A. Janssen, Reduced risk of relapse after long-term nucleos(t)ide analogue consolidation therapy for chronic hepatitis B, Alimentary Pharmacology & Therapeutics, 2015, 41, 8
  13. 13
    George V. Papatheodoridis, Henry Lik-Yuen Chan, Bettina E. Hansen, Harry L.A. Janssen, Pietro Lampertico, Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy, Journal of Hepatology, 2015, 62, 4, 956

    CrossRef

  14. 14
    Maria-Carlota Londoño, Javier Hernández-Blanco, Alvaro Díaz-Gonzalez, Sustained Virological Response and Hepatitis C-Related Cirrhosis: a World of Opportunities, Current Hepatology Reports, 2015, 14, 1, 32

    CrossRef

  15. 15
    Hui Y. Zhao, Sen Liu, Jian He, Chao C. Pan, Hui Li, Zheng Y. Zhou, Yin Ding, Da Huo, Yong Hu, Synthesis and application of strawberry-like Fe3O4-Au nanoparticles as CT-MR dual-modality contrast agents in accurate detection of the progressive liver disease, Biomaterials, 2015, 51, 194

    CrossRef

  16. 16
    Hans Dieter Nischalke, Philipp Lutz, Benjamin Krämer, Jennifer Söhne, Tobias Müller, Jonas Rosendahl, Janett Fischer, Thomas Berg, Kanishka Hittatiya, Hans-Peter Fischer, Michael Soyka, Nasser Semmo, Jacob Nattermann, Tilman Sauerbruch, Christian P. Strassburg, Felix Stickel, Ulrich Spengler, A common polymorphism in the NCAN gene is associated with hepatocellular carcinoma in alcoholic liver disease, Journal of Hepatology, 2014, 61, 5, 1073

    CrossRef

  17. 17
    Stuart C. Gordon, Lois E. Lamerato, Loralee B. Rupp, Jia Li, Scott D. Holmberg, Anne C. Moorman, Philip R. Spradling, Eyasu H. Teshale, Vinutha Vijayadeva, Joseph A. Boscarino, Emily M. Henkle, Nancy Oja–Tebbe, Mei Lu, Antiviral Therapy for Chronic Hepatitis B Virus Infection and Development of Hepatocellular Carcinoma in a US Population, Clinical Gastroenterology and Hepatology, 2014, 12, 5, 885

    CrossRef

  18. 18
    Harry L.A. Janssen, Ambreen Arif, Averting Hepatocellular Carcinoma in Chronic Hepatitis B With Antiviral Therapy: Tipping the Balance or Not Yet?, Gastroenterology, 2014, 147, 1, 24

    CrossRef

  19. 19
    G. L.-H. Wong, V. W.-S. Wong, H. L.-Y. Chan, Combination therapy of interferon and nucleotide/nucleoside analogues for chronic hepatitis B, Journal of Viral Hepatitis, 2014, 21, 12
  20. 20
    Soon Sun Kim, Jae Chul Hwang, Sun Gyo Lim, Seon Joo Ahn, Jae Youn Cheong, Sung Won Cho, Effect of Virological Response to Entecavir on the Development of Hepatocellular Carcinoma in Hepatitis B Viral Cirrhotic Patients: Comparison Between Compensated and Decompensated Cirrhosis, The American Journal of Gastroenterology, 2014, 109, 8, 1223

    CrossRef

  21. 21
    Henry L.Y. Chan, Chi Kuen Chan, Aric Josun Hui, Sing Chan, Fred Poordad, Ting-Tsung Chang, Philippe Mathurin, John F. Flaherty, Lanjia Lin, Amy Corsa, Anuj Gaggar, G. Mani Subramanian, John G. McHutchison, Sam Lee, Edward J. Gane, Effects of Tenofovir Disoproxil Fumarate in Hepatitis B e Antigen-Positive Patients With Normal Levels of Alanine Aminotransferase and High Levels of Hepatitis B Virus DNA, Gastroenterology, 2014, 146, 5, 1240

    CrossRef

  22. 22
    Hui Y Yang, Nai Q Zheng, Dong M Li, Lin Gu, Xiao M Peng, Entecavir combined with furin inhibitor simultaneously reduces hepatitis B virus replication and e antigen secretion, Virology Journal, 2014, 11, 1, 165

    CrossRef

  23. 23
    Gin-Ho Lo, Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with cirrhosis: Facts or fiction?, Hepatology, 2014, 60, 5
  24. 24
    Christian Trépo, Henry L Y Chan, Anna Lok, Hepatitis B virus infection, The Lancet, 2014, 384, 9959, 2053

    CrossRef

  25. 25
    Xiao Hui Zhang, Ru Feng, Lan Ping Xu, Qian Jiang, Hao Jiang, Hai Xia Fu, Hui Liu, Ting Niu, Xin Wang, Jian Da Hu, Ming Jiang, Zhao Wang, Jing Wen Wang, Hui Ma, Yan Di Xie, Xiao Lu Zhu, Hao Wang, Lai Wei, Xiao-Jun Huang, Immunosuppressive treatment combined with nucleoside analog is superior to nucleoside analog only in the treatment of severe thrombocytopenia in patients with cirrhosis associated with hepatitis B in China: A multicenter, observational study, Platelets, 2014, 1

    CrossRef

  26. 26
    Ryoko Yamada, Naoki Hiramatsu, Tsugiko Oze, Naoki Morishita, Naoki Harada, Takayuki Yakushijin, Sadaharu Iio, Yoshinori Doi, Akira Yamada, Akira Kaneko, Hideki Hagiwara, Eiji Mita, Masahide Oshita, Toshifumi Itoh, Hiroyuki Fukui, Taizo Hijioka, Kazuhiro Katayama, Shinji Tamura, Harumasa Yoshihara, Yasuharu Imai, Michio Kato, Takuya Miyagi, Yuichi Yoshida, Tomohide Tatsumi, Akinori Kasahara, Toshimitsu Hamasaki, Norio Hayashi, Tetsuo Takehara, Impact of alpha-fetoprotein on hepatocellular carcinoma development during entecavir treatment of chronic hepatitis B virus infection, Journal of Gastroenterology, 2014,

    CrossRef

  27. 27
    C.-C. Hung, S.-M. Wu, P.-H. Lin, W.-H. Sheng, Z.-Y. Yang, H.-Y. Sun, M.-S. Tsai, K.-Y. Lee, M.-S. Huang, S.-F. Chang, Y.-C. Su, W.-C. Liu, S.-Y. Chang, Increasing Incidence of Recent Hepatitis D Virus Infection in HIV-Infected Patients in an Area Hyperendemic for Hepatitis B Virus Infection, Clinical Infectious Diseases, 2014, 58, 11, 1625

    CrossRef

  28. 28
    Byung-Cheol Song, Yoo-Kyung Cho, Hyeyoung Jwa, Eun Kwang Choi, Heung Up Kim, Hyun Joo Song, Soo-Young Na, Sun-Jin Boo, Seung Uk Jeong, Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?, Clinical and Molecular Hepatology, 2014, 20, 4, 355

    CrossRef

  29. You have free access to this content29
    JSH Guidelines for the Management of Hepatitis B Virus Infection, Hepatology Research, 2014, 44,
  30. 30
    Young–Suk Lim, Seungbong Han, Nae–Yun Heo, Ju Hyun Shim, Han Chu Lee, Dong Jin Suh, Mortality, Liver Transplantation, and Hepatocellular Carcinoma Among Patients With Chronic Hepatitis B Treated With Entecavir vs Lamivudine, Gastroenterology, 2014, 147, 1, 152

    CrossRef

  31. You have free access to this content31
    G. L.-H. Wong, H. L.-Y. Chan, P. C.-L. Choi, A. W.-H. Chan, Z. Yu, J. W.-Y. Lai, H.-Y. Chan, V. W.-S. Wong, Non-invasive algorithm of enhanced liver fibrosis and liver stiffness measurement with transient elastography for advanced liver fibrosis in chronic hepatitis B, Alimentary Pharmacology & Therapeutics, 2014, 39, 2
  32. 32
    Jian-Hong Zhong, Nucleos(t)ide analogue therapy for HBV-related HCC after hepatic resection: clinical benefits and unanswered questions, Tumor Biology, 2014, 35, 12, 12779

    CrossRef

  33. 33
    J. Liu, T.-C. Tseng, H.-I. Yang, M.-H. Lee, R. Batrla-Utermann, C.-L. Jen, S.-N. Lu, L.-Y. Wang, S.-L. You, P.-J. Chen, C.-J. Chen, J.-H. Kao, Predicting Hepatitis B Virus (HBV) Surface Antigen Seroclearance in HBV e Antigen-Negative Patients With Chronic Hepatitis B: External Validation of a Scoring System, Journal of Infectious Diseases, 2014,

    CrossRef

  34. 34
    Hye Won Lee, Eun Jin Yoo, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Prediction of Development of Liver-Related Events by Transient Elastography in Hepatitis B Patients With Complete Virological Response on Antiviral Therapy, The American Journal of Gastroenterology, 2014, 109, 8, 1241

    CrossRef

  35. 35
    Mi Na Kim, Kwang-Hyub Han, Sang Hoon Ahn, Prevention of Hepatocellular Carcinoma: Beyond Hepatitis B Vaccination, Seminars in Oncology, 2014,

    CrossRef

  36. 36
    Grace Lai-Hung Wong, Henry Lik-Yuen Chan, Vincent Wai-Sun Wong, Reply, Hepatology, 2014, 60, 5
  37. 37
    Massimo Colombo, Massimo Iavarone, Role of antiviral treatment for HCC prevention, Best Practice & Research Clinical Gastroenterology, 2014, 28, 5, 771

    CrossRef

  38. You have free access to this content38
    J. Sun, X. Liang, V. W.-S. Wong, Commentary: prognostication of chronic hepatitis B - are Fibrotest and Fibroscan the final answers?, Alimentary Pharmacology & Therapeutics, 2013, 37, 11
  39. 39
    Cheng-Yuan Peng, Nucleos(t)ide Analogues Therapy for Chronic Hepatitis B in Taiwan: Short-Term Versus Long-Term, Current Hepatitis Reports, 2013, 12, 3, 181

    CrossRef

  40. 40
    Grace Lai-Hung Wong, Ching-Ning Chong, Vincent Wai-Sun Wong, Tertiary Prevention of HBV-related HCC in Asia, Current Hepatitis Reports, 2013, 12, 3, 157

    CrossRef